C
CorMedix Inc. (CRMD)
NGM – Real Time Price. Currency in USD
6.71
+0.01 (0.15%)
At close: Mar 27, 2026, 4:00 PM EDT
6.71
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:41 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
6.71
+0.01 (0.15%)
At close: Mar 27, 2026, 4:00 PM EDT
6.71
0.00 (0.00%)
After-hours: Mar 27, 2026, 7:41 PM EDT
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
| Name | Position |
|---|---|
| Donna Ucci | Senior VP & Head of Global Quality |
| Dr. Matthew T. David M.D. | EVP & Chief Business Officer |
| Dr. Peter Sullivan BCOP, Pharm.D. | Senior Vice President of Market Access |
| Dr. Tushar Mukherjee | Senior VP & Head of Technical Operations |
| Mr. Jared L. Crandon Pharm.D. | Executive Director of Clinical Portfolio Management |
| Mr. Michael Seckler | EVP & Chief Commercial Officer |
| Ms. Beth Steinbrenner | SVP & Chief Human Resource Officer |
| Date | Type | Document |
|---|---|---|
| 2026-03-06 | 8-K | ea0280394-8k_cormedix.htm |
| 2026-03-05 | 8-K | ea027968001-8k_cormedix.htm |
| 2026-01-08 | 8-K | ea0272149-8k_cormedix.htm |
| 2025-11-13 | S-8 | ea0264891-s8_cormedix.htm |
| 2025-11-12 | 10-Q | ea0264325-10q_cormedix.htm |
| 2025-10-24 | DEF 14A | ea0261891-01.htm |
| 2025-10-20 | 8-K | ea0261760-8k_cormedix.htm |
| 2025-10-14 | PRER14A | ea0260783-01.htm |
| 2025-10-07 | RW | ea0260559-rw_cormedix.htm |
| 2025-10-06 | RW | ea0260274-rw_cormedix.htm |
| Ms. Elizabeth Masson-Hurlburt B.A. |
| Executive VP, Chief Operating Officer & Chief Integration Officer |
| Ms. Kaufman Beth Zelnick Esq. | EVP, Chief Legal and Compliance Officer & Corporate Secretary |
| Ms. Susan Blum | EVP & Chief Financial Officer |